Delivery Order SPE2DB24D2003-SPE2DB25FXHG4
Award Date
4/30/25
Potential Completion Date
5/1/25
Potential Value
$4.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Descovy 200-25 mg tablet, a medication, with a ceiling value of $26,074.08. The contract is a Firm Fixed Price, non-set-aside contract with an ultimate completion date of April 8, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $32,170.01, is for the delivery of Descovy 200-25 mg tablets over a period ending on April 24, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Descovy 200-25 mg tablets, a prescription medication, with a ceiling value of $2,842.20 and a period of performance through April 2025. The contract is a firm fixed-price delivery order and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,266.87, is for the delivery of Descovy 200-25 mg tablets to support federal healthcare programs. The contract is a firm fixed-price delivery order with an ultimate completion date of August 7, 2024. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,574.17, is for the delivery of Descovy 200-25 mg tablets, a prescription medication, to support federal healthcare programs. The contract has a fixed-price, firm-fixed-price structure and a period of performance through May 2024. The contract is not designated as a set-aside....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,012.81, is for the delivery of Descovy 200-25 mg tablets over the period ending on April 29, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999.00, which provides a comprehensive global...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,889.96, is for the supply of Descovy 200-25 mg tablets to support federal healthcare programs. The contract is a firm fixed-price, Indefinite Delivery Contract (IDC) that runs through December 2024, with no set-aside designation. AmerisourceBergen holds a larger $999,999,999 IDC with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,939.67 firm fixed-price contract is for the supply of Descovy 200-25 mg tablet. The contract has a period of performance through December 19, 2023 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of Descovy 200-25 mg tablets, a pharmaceutical product, with a ceiling value of $5,675.00. The contract has a performance period ending on May 1, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Descovy 200-25 mg tablets, a prescription medication, with a ceiling value of $18,417.91. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no indication of any major subcontractors. The...